TJP2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.314000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.613000E-01
Normal-vs-Stage2
2.514400E-01
Normal-vs-Stage3
9.679600E-01
Normal-vs-Stage4
1.910750E-01
Stage1-vs-Stage2
4.598200E-01
Stage1-vs-Stage3
5.559800E-01
Stage1-vs-Stage4
1.575610E-01
Stage2-vs-Stage3
1.656760E-01
Stage2-vs-Stage4
2.050200E-01
Stage3-vs-Stage4
1.843820E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.560400E-01
Normal-vs-AfricanAmerican
4.560400E-01
Normal-vs-Asian
1.976830E-01
Caucasian-vs-AfricanAmerican
9.327000E-01
Caucasian-vs-Asian
2.255200E-01
AfricanAmerican-vs-Asian
5.229800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.917000E-01
Normal-vs-Female
4.117600E-01
Male-vs-Female
1.442650E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.757600E-01
Normal-vs-Age(41-60Yrs)
1.879450E-01
Normal-vs-Age(61-80Yrs)
4.373600E-01
Normal-vs-Age(81-100Yrs)
3.253600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.716180E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.125600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.901000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.907900E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.674400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.975000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.233800E-01
Normal-vs-Daily Drinker
3.810400E-01
Normal-vs-Weekly Drinker
6.446600E-01
Normal-vs-Occasional Drinker
3.043200E-01
Normal-vs-Social Drinker
4.064200E-01
Non Drinker-vs-Daily Drinker
9.172400E-01
Non Drinker-vs-Weekly Drinker
6.503600E-01
Non Drinker-vs-Occasional Drinker
4.996200E-01
Non Drinker-vs-Social Drinker
5.945200E-01
Daily Drinker-vs-Weekly Drinker
7.347600E-01
Daily Drinker-vs-Occasional Drinker
4.900400E-01
Daily Drinker-vs-Social Drinker
6.896000E-01
Weekly Drinker-vs-Occasional Drinker
4.207800E-01
Weekly Drinker-vs-Social Drinker
9.718200E-01
Occasional Drinker-vs-Social Drinker
3.198600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.100780E-01
Normal-vs-Grade 2
1.453830E-02
Normal-vs-Grade 3
1.368460E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.976300E-02
Grade 1-vs-Grade 3
4.404400E-03
Grade 1-vs-Grade 4
1.100780E-01
Grade 2-vs-Grade 3
5.990300E-02
Grade 2-vs-Grade 4
1.453830E-02
Grade 3-vs-Grade 4
1.368460E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.422200E-01
Normal-vs-NonDiabetic
2.878400E-01
Diabetic-vs-NonDiabetic
3.537000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.333600E-01
Normal-vs-NoPancreatitis
3.740000E-01
Pancreatitis-vs-NoPancreatitis
6.106000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.149600E-01
Normal-vs-N1
2.806800E-01
N0-vs-N1
4.331800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.761800E-02
Normal-vs-TP53-NonMutant
4.462000E-01
TP53-Mutant-vs-TP53-NonMutant
3.435600E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
